PHR Share Price Performance
zł3.52
-0.84 (-19.27%)
Price zł3.52
Share Pricen/a
Pharmena S.A. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
PHR Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Pharmena S.A. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 28, 2026
- -0.25
- 83.26%
- -175.59%
- 0%
About PHR
- Founded
- 2002
- Employees
- 7
- CEO
- WebsiteView website
Pharmena S.A. engages in the sale of dietary supplements in Poland and internationally. It also develops 1-MNA (PHR-701 program), a medical device for use in difficult-to-heal wounds. In addition, the company is involved in research and development of therapeutic applications of 1 MNA as an anti-inflammatory and anti-fibrotic drug; and research and development at pulmonary fibrosis, respiratory tract infections, including viral infections, COVID-19, inflammatory diseases, metabolic diseases and other therapeutic applications. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. operates as a subsidiary of Pelion S.A.
